WECARE: A Behavioral Intervention for Dementia Caregivers

Sponsor
George Mason University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05992467
Collaborator
(none)
45
1
12

Study Details

Study Description

Brief Summary

This study aims to pilot test a culturally tailored behavioral intervention called "WECARE" to enhance caregiving mastery and improve psychosocial wellbeing of Chinese American family caregivers of persons with Alzheimer's Disease and related dementia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Wellness Enhancement for Caregivers (WECARE)
N/A

Detailed Description

The investigators propose to test a culturally tailored behavioral intervention to enhance caregiving mastery and improve psychosocial wellbeing among Chinese American family caregivers of persons living with Alzheimer's Disease and related dementia. This intervention, Wellness Enhancement for Caregivers (WECARE), will be delivered via WeChat, a social media app highly popular among Chinese Americans. About 45 participants will be recruited for the pilot test. Participants will complete a baseline survey, receive 7-week WECARE program on their WeChat accounts, complete a follow-up survey 12 weeks after the baseline, and then a qualitative interview on Zoom.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
WECARE: A Social Media-based Personalized Intervention to Enhance Caregiving Mastery Among Chinese American Dementia Caregivers
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: WECARE

Participants will first complete a baseline survey online, then subscribe to the WECARE official account on their own WeChat accounts and begin receiving the 7-week interactive and personalized program. The program content includes short video clips, pictorial messages, and audio recordings. Each week, the WECARE program is focused on a theme aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Four weeks after the intervention or 11 weeks after the baseline, participants will complete a follow-up survey online.

Behavioral: Wellness Enhancement for Caregivers (WECARE)
WECARE behavioral intervention is guided by behavioral theories aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Participants will receive multimedia content on their WeChat account on cellphone or tablet, including short video clips, pictorial messages, short articles, and audio recordings 6 days a week, for 7 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in depressive symptoms [Baseline (week 0 or 1 week before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention]

    The baseline and follow-up differences in depressive symptoms will be assessed. Depressive symptoms will be measured by the CES-D, a 20-item survey instrument. The total score will be calculated to quantify depressive symptoms. The baseline and follow-up differences in the scores will be calculated.

Secondary Outcome Measures

  1. Change in caregiving burden [Baseline (week 0 or 1 week before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention]

    The baseline and follow-up differences in caregiving burden will be assessed. Caregiving burden will be measured by the Zarit Burden Interview, a 12-item survey instrument. The total score will be calculated to quantify caregiving burden. The baseline and follow-up differences in the scores will be calculated.

  2. Change in life satisfaction [Baseline (week 0 or 1 week before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention]

    The baseline and follow-up differences in life satisfaction will be assessed. Life satisfaction will be measured by the Life Satisfaction Scale, a 5-item survey instrument. The total score will be calculated to quantify life satisfaction. The baseline and follow-up differences in the scores will be calculated.

Other Outcome Measures

  1. Change in caregiving mastery [Baseline (week 0 or 1 week before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention]

    The baseline and follow-up differences in caregiving mastery will be assessed. Caregiving mastery will be measured by the Caregiving Mastery Scale, a 7-item survey instrument. The total score will be calculated to quantify caregiving mastery. The baseline and follow-up differences in the scores will be calculated.

  2. Change in care-recipient's problem behaviors [Baseline (week 0 or 1 week before the intervention) and follow-up (week 11-12, or 4-5 weeks after the intervention]

    The baseline and follow-up differences in care-recipient's problem behaviors will be assessed. Care-recipient's problem behaviors will be measured by a list of 20-item problem behaviors. The total score will be calculated to quantify the number of problem behaviors. The baseline and follow-up differences in the scores will be calculated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. 21 years or older,

  2. self-identified as Chinese or Chinese American,

  3. speak and read Chinese (Mandarin or Cantonese),

  4. own a smartphone and use WeChat,

  5. living in Washington DC metropolitan, and

  6. currently care for a family member with ADRD and provide care for more than 10 hours a week.

Exclusion Criteria:
  1. do not read or speak Chinese,

  2. care-recipient is in hospice care or have a life expectancy less than 6 months,

  3. signs of severe intellectual deficits or psychotic disorders, or

  4. unable to provide informed consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • George Mason University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Y. Alicia Hong, Professor, George Mason University
ClinicalTrials.gov Identifier:
NCT05992467
Other Study ID Numbers:
  • George Mason University
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2023